In contrast to the well characterized beta-adrenergic receptor- adenylate cyclase system, the plasma membrane components which couple the alpha 1-adrenergic receptor to intracellular calcium mobilization remain unidentified.
The specific aims of this proposal are to: 1) develop a reliable method to purify large amounts of the alpha 1-adrenergic receptor from the DDT1 MF-2 cell line, 2) obtain polyclonal and monoclonal antibodies against the alpha 1-adrenergic receptor, and 3) using a hamster lambda gtll library, isolate a complementary DNA (cDNA) from which the primary amino acid sequence of the alpha 1-adrenergic receptor will be deduced. DDT1 MF-2 cells are the starting point for receptor purification. We plan to use a combination of affinity chromatography and size exclusion HPLC to obtain sufficient purified receptor for sequencing using a ga phase protein sequenator and for immunization of mice and rabbits to produce anti-receptor polyclonal and monoclonal antibodies. For sequence information, oligodeoxynucleotides will be synthesized. The oligodeoxynucleotides and anti-receptor antibodies will be used to screen a lambda gtll cDNA library already established in our laboratory. The isolated DNA sequence complementary to the alpha 1-adrenergic receptor mRNA will be transfected into 6580 cells, derived from a hamster uterine leiomyosarcoma, which lack alpha 1-adrenergic receptors. Unidirectional 45 Ca+2 efflux and radioligand assays will be performed to determine whether functional alpha 1-adrenergic receptor is inserted into the plasma membrane by this procedure. The long term goals are to use the probes (antibodies and cDNA) generated in this project to study the membrane events associated with alpha 1-adrenergic stimulation, to study regulation of receptor function and to obtain the genomic DNA sequence and structure which codes for the alpha 1-adrenergic receptor. The availability of antibodies and cDNA probes should provide investigators new tools with which to study disease states (e.g. hypertension) which possibly involve the alpha 1-adrenergic receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM030669-06
Application #
3278479
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1983-12-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Cornett, L E; Hiller, F C; Jacobi, S E et al. (1998) Identification of a glucocorticoid response element in the rat beta2-adrenergic receptor gene. Mol Pharmacol 54:1016-23
Jones, S M; Deng, C L; MacLeod, V et al. (1997) Evidence for alternative splicing in hepatic alpha 1B-adrenergic receptor gene expression. J Recept Signal Transduct Res 17:815-32
McGraw, D W; Chai, S E; Hiller, F C et al. (1995) Regulation of the beta 2-adrenergic receptor and its mRNA in the rat lung by dexamethasone. Exp Lung Res 21:535-46
Deng, C L; Cornett, L E (1994) Regulation of alpha 1b-adrenergic receptor gene expression in rat liver cell lines. Biochim Biophys Acta 1219:669-76